Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 36 (1) , 1-7
- https://doi.org/10.1016/0952-3278(89)90154-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The in vitro effect of amrinone on thromboxane B2 synthesis in human whole bloodThrombosis Research, 1986
- Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patientsEuropean Journal of Clinical Pharmacology, 1986
- Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.Circulation, 1985
- Platelet β‐adrenoceptorsBritish Journal of Pharmacology, 1983
- A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality resultsJAMA, 1982
- PLATELET AGGREGATION AND BETA-BLOCKERSThe Lancet, 1982
- ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENTThe Lancet, 1981
- Effect of propranolol on platelet functionBlood, 1977
- The effect of various beta-receptor blocking agents on platelet aggregationCellular and Molecular Life Sciences, 1969
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962